We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

105 hedge funds and large institutions have $136M invested in VanEck Biotech ETF in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $355K

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

11% more capital invested

Capital invested by funds: $123M → $136M (+$13.4M)

2.41% more ownership

Funds ownership: 25.65% → 28.06% (+2.4%)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

3% less funds holding

Funds holding: 108 → 105 (-3)

Holders
105
Holders Change
-3
Holders Change %
-2.78%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
30
Reduced
26
Closed
9
Calls
$1.37M
Puts
$355K
Net Calls
+$1.01M
Net Calls Change
+$1.25M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$9.04M
2
FP
Financial Perspectives
Minnesota
+$2.78M
3
FFN
Focus Financial Network
Minnesota
+$2.52M
4
HighTower Advisors
HighTower Advisors
Illinois
+$1.91M
5
GT
Glenview Trust
Kentucky
+$1.68M

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.8M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.34M
3
Citadel Advisors
Citadel Advisors
Florida
-$976K
4
RJA
Raymond James & Associates
Florida
-$720K
5
HPCM
Hunter Perkins Capital Management
Illinois
-$556K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAL
76
Capital Analysts LLC
Pennsylvania
$71K +$72.9K +403 New
First Manhattan
77
First Manhattan
New York
$70K – – –
AIC
78
Ameritas Investment Company
Nebraska
$65.1K +$67.1K +371 New
EIP
79
Ellis Investment Partners
Pennsylvania
$62K – – –
EVM
80
Eaton Vance Management
Massachusetts
$54K +$55.2K +305 New
HI
81
Harbour Investments
Wisconsin
$49K +$50.5K +279 New
TC
82
Truvestments Capital
Florida
$48K – – –
KPCM
83
Kings Point Capital Management
New York
$47K – – –
AF
84
Arrow Financial
New York
$44K – – –
AIM
85
Anchor Investment Management
South Carolina
$27.2K – – –
AF
86
Allworth Financial
California
$27K +$21.7K +120 +375%
US Bancorp
87
US Bancorp
Minnesota
$26K – – –
Carson Wealth (CWM LLC)
88
Carson Wealth (CWM LLC)
Nebraska
$24K – – –
Simplex Trading
89
Simplex Trading
Illinois
$21K -$127K -700 -85%
APWM
90
Atlas Private Wealth Management
New York
$18K -$2.71K -15 -13%
M
91
MOTCO
Texas
$18K – – –
WT
92
Whittier Trust
California
$18K – – –
CAPTRUST Financial Advisors
93
CAPTRUST Financial Advisors
North Carolina
$14K – – –
CFA
94
Carroll Financial Associates
North Carolina
$13K – – –
NFG
95
Next Financial Group
Texas
$13K – – –
ADL
96
Asset Dedication LLC
California
$11K – – –
Fidelity Investments
97
Fidelity Investments
Massachusetts
$9K -$10.3K -57 -52%
AA
98
Ancora Advisors
Ohio
$9K – – –
FP
99
Fiduciary Planning
Florida
$9K +$9.04K +50 New
SWM
100
Spire Wealth Management
Virginia
$9K +$9.04K +50 New
1 2 3
4
5

BBH Hedge Fund Activity: Q1 2021 in Review

105 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2021, worth a combined $136M — up 11% from $123M a quarter earlier.

Fund positioning in BBH was balanced in Q1 2021: 9 funds opened new positions, 9 closed out, 30 added to existing stakes and 26 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $9.04M. The largest seller was Royal Bank of Canada, cutting an estimated $1.8M.

  • 105 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2021, down from 108 in Q4 2020.
  • Funds reported $136M of VanEck Biotech ETF stock for Q1 2021, up 11% quarter-over-quarter.
  • 9 funds opened new VanEck Biotech ETF positions in Q1 2021 and 9 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2021 was Goldman Sachs, an estimated $9.04M added.
  • The largest VanEck Biotech ETF seller in Q1 2021 was Royal Bank of Canada, an estimated $1.8M sold.

Based on aggregated 13F filings for Q1 2021.